Voting Rights and Capital

28 Sep 2007 15:06

Ark Therapeutics Group PLC28 September 2007 28 September 2007 Ark Therapeutics Group plc Voting Rights and Capital In accordance with the FSA's Disclosure and Transparency Rules, Ark TherapeuticsGroup plc (LSE: AKT) ("Ark" or the "Company") confirms that as at the date ofthis announcement the Company's issued share capital consists of 166,302,680ordinary shares with voting rights. This figure may be used by shareholders as the denominator for the calculationsby which they will determine if they are required to notify their interest in,or a change to the interest in, Ark under the FSA's Disclosure and TransparencyRules. - Ends - This information is provided by RNS The company news service from the London Stock Exchange